Search

Author/Creator Unterlauft, Astrid

1. Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial. Issue 2 (February 2023)

Authors:
Köhler, Wolfgang; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana; Pizcueta, Pilar; Rodríguez-Pascau, Laura; Tra...
Journal:
Lancet neurology
Issue:
Volume 22:Issue 2(2023)
Page Start:
127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Issue 5 (May 2023)

Authors:
Bril, Vera; Drużdż, Artur; Grosskreutz, Julian; Habib, Ali A; Mantegazza, Renato; Sacconi, Sabrina; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Boehnlein, Marion; Bozorg, Ali; Gayfieva, Maryam; Greve, Bernhard; Woltering, Franz; Kaminski, Henry J; Genge, Angela; Massie, Rami; Berube, Maxime; Br...
Journal:
Lancet neurology
Issue:
Volume 22:Issue 5(2023)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search